Post Reply
121-140 of 5056
Should test the high on Monday ....0.46
Newbornborn ( Date: 09-May-2026 12:16) Posted:
|
Yes , not hope
stlimst ( Date: 09-May-2026 10:32) Posted:
|
T K K
kye_lin ( Date: 09-May-2026 09:31) Posted:
|
Good point. Know the company you are investing in.
The CEO, the directors and SSH all know what IX BioPharma can bring to the table and the true value of the company.
Almost certain IX BioPharma will be very profitable in time to come...not a hope.
The CEO, the directors and SSH all know what IX BioPharma can bring to the table and the true value of the company.
Almost certain IX BioPharma will be very profitable in time to come...not a hope.
JAMMIE ( Date: 09-May-2026 09:37) Posted:
|
I do my research before buying and then hope it turns out well.
I have hoped for forty or more years and it has worked ok for me.
Bought my first stock in 1984.
I have hoped for forty or more years and it has worked ok for me.
Bought my first stock in 1984.
JAMMIE ( Date: 09-May-2026 09:37) Posted:
|
Actually the loss is well expected. No one is expecting such a substantial loss in previous year to become a profit overnight
ahberngh ( Date: 09-May-2026 08:33) Posted:
|
Those who are holding long and know the market are not bothered.
There are reasons why recent months volume are high. There will be people to pick up the 9.4m. Longists are holding for reasons the blind cannot see.
There are reasons why recent months volume are high. There will be people to pick up the 9.4m. Longists are holding for reasons the blind cannot see.
come monday the new 9.4 millions new share awards given free can start dumping n ceo extra 1 mill also approved in agm can also join the xxxxxxxx
if only hope worked in the stock market then every one of us will be laughing our way to the banks. dont hope, trust the data and have conviction in your stock pick. if you are not sure then dont invest in that stock. but dont leave it on hope.
ahberngh ( Date: 09-May-2026 08:33) Posted:
|
Monday go back to 30s....
Hopefully can become profitable (for the first time since its ipo ??) in another
one or two quarters.
Wait and see.
one or two quarters.
Wait and see.
iX Biopharma Q3 FY2026 results show narrowing losses and stronger balance sheet, but revenue remains under pressure from weaker medicinal cannabis demand. The highlight is a US$40.95M US Department of Defense contract for Wafermine, which materially strengthens its R& D pipeline and cash position.
📊 Key Financials (Unaudited, 9M FY2026 vs 9M FY2025)
| Metric | 9M FY2026 | 9M FY2025 | Change |
|---|---|---|---|
| Revenue | S$4.76M | S$5.53M | &darr 14% |
| Gross Profit | S$1.42M | S$1.33M | &uarr 7% |
| Gross Margin | 30% | 24% | &uarr 6pp |
| Net Loss | S$2.97M | S$8.44M | &darr 65% |
| Basic LPS | (0.32¢ ) | (0.96¢ ) | Narrowed |
| Cash & Equivalents | S$16.49M | S$0.87M (Jun 2025) | Strong recovery |
| Net Assets | S$17.0M | S$0.37M (Jun 2025) | Material improvement |
📈 Operational Highlights
- Medicinal Cannabis: Revenue fell 41% YoY (9M26: S$2.76M vs S$4.66M) due to import clearance delays and sector contraction in Australia.
- Nutraceuticals: Strong growth, +100% YoY (S$1.31M vs S$0.66M), driven by SL‑ NAD⁺ sales in the U.S. and China.
- Other Pharma & Services: Contributed ~S$0.47M, diversifying revenue mix.
- Gross Margin improved to 30% (from 24%) thanks to better sales mix and cost control.
💰 Balance Sheet & Cash Flow
- Cash position surged to S$16.5M after two private placements (S$20.8M) and warrant conversions.
- Working capital restored: +S$11.3M vs a deficit of &ndash S$4.8M in June 2025.
- Liabilities stable at ~S$10.4M, with borrowings ~S$5.9M.
- Operating cash outflow: S$4.87M (higher YoY due to resumed R& D).
- Financing inflows: S$20.5M, main driver of liquidity recovery.
🚀 Strategic Developments
-
Wafermine (sublingual ketamine wafer):- Awarded US$40.95M DoD contract in Feb 2026.
- Supports Phase 3 trials and potential Emergency Use Authorization (EUA) for battlefield deployment.
- Positions iX as a non‑ opioid pain treatment provider in the U.S. market.
-
WaferlogiX peptide platform: Preclinical data shows ~20x higher absorption for sublingual semaglutide vs oral forms. Pipeline includes GLP‑ 1 wafers for diabetes and weight management. -
Nutraceuticals: SL‑ NAD⁺ gaining traction in U.S. longevity market featured by Dr. Peter Attia boosted awareness. -
Corporate Restructuring: Plans to establish a U.S.‑ based manufacturing and distribution vehicle, enabling direct market entry and compounding pharmacy expansion.
⚠ ️ Risks & Considerations
- Revenue contraction in medicinal cannabis remains a drag.
- R& D expenses will rise as Wafermine Phase 3 progresses.
- Reliance on equity financing &mdash recent placements improved liquidity, but dilution risk persists.
- Regulatory hurdles: FDA approval timelines for Wafermine and peptide wafers remain uncertain.
🎯 Takeaway
iX Biopharma Q3 FY2026 results show improved margins, narrowed losses, and a fortified balance sheet. The DoD Wafermine contract is a game‑ changer, providing funding and validation. Near‑ term growth hinges on nutraceutical momentum (SL‑ NAD⁺ ) and execution of the U.S. compounding pharmacy strategy, while investors should watch for Phase 3 Wafermine milestones and continued cash discipline.
NAV : 1.6 cent
Loss per share : 0.32 cent
https://links.sgx.com/1.0.0/corporate-announcements/E4SII570ZA7PMUBF/888192_iX%20Biopharma%2026Q3%20Results%20Announcement%20Final.pdf
Loss per share : 0.32 cent
https://links.sgx.com/1.0.0/corporate-announcements/E4SII570ZA7PMUBF/888192_iX%20Biopharma%2026Q3%20Results%20Announcement%20Final.pdf
piscesmonkey ( Date: 08-May-2026 22:41) Posted:
|
Loss making
No worries, the day will come when you see IX BioPharma' s share price shoots thru the roof.
Don' t be unduly affected by daily price fluctuation - as Bro spurfan said, this is washing plate/tray or cleaning up to get ready for the big move.
Will come.
Have a good weekend.
Don' t be unduly affected by daily price fluctuation - as Bro spurfan said, this is washing plate/tray or cleaning up to get ready for the big move.
Will come.
Have a good weekend.
ahberngh ( Date: 08-May-2026 17:43) Posted:
|
洗 盘 (xǐ pán): Literally "wash the plate/tray." This is a broader term for a "washout" or "cleaning up" of short-term investors, often used interchangeably with zhèn cā ng
Someone or a few people are suppressing.
At one point in the afternoon, it was trying to break
through 42c, then quickly more selling come in at 41.5c
and push down to 41c.
Not sure why all this control???
At one point in the afternoon, it was trying to break
through 42c, then quickly more selling come in at 41.5c
and push down to 41c.
Not sure why all this control???
Trying very hard to break 0.42
Range bound for q sometime
Many contra due today, hope BBS push up to help to unload